Skip to main content

GE HealthCare Technologies Inc. net margin

  • GEHC · Nasdaq
  • Medical devices
  • Health Care Equipment
  • S&P 500
$83.02+1.44%Close 13 Nov 2026 · Market value $37.71B

GE HealthCare Technologies Inc.'s net margin was 10.1% for fiscal year 2025 (the twelve months to 31 Dec 2025), unchanged from fiscal 2024.

In the third quarter of fiscal 2026 (the three months to 30 Sep 2026) it was 11.2%, up 2.5 points from a year earlier.

From GE HealthCare Technologies Inc.'s annual and quarterly reports, compiled and checked by AapWire. Latest report filed 28 Oct 2026.

Fiscal 2025
10.1%
−0.0 pts
Q3 FY2026
11.2%
+2.5 pts on a year
Average over 5 years
10.3%
FY 2021–FY 2025

Net margin by fiscal year

12.8%FY 202110.4%FY 2022−2.3 pts8.0%FY 2023−2.4 pts10.1%FY 2024+2.1 pts10.1%FY 2025−0.0 pts

Change in points on the year before, under each year. From FY 2021 to FY 2025, GE HealthCare Technologies Inc.'s net margin went from 12.8% to 10.1%; the highest was 12.8% in FY 2021.

GE HealthCare Technologies Inc. net margin, fiscal years
PeriodFY 2021FY 2022FY 2023FY 2024FY 2025
Net margin12.8%10.4%8.0%10.1%10.1%
Period end31 Dec 202131 Dec 202231 Dec 202331 Dec 202431 Dec 2025

Net margin by quarter

The last eight fiscal quarters. Each is compared with the same quarter a year earlier on the company's page.

GE HealthCare Technologies Inc. net margin, fiscal quarters
PeriodQ4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Net margin13.6%11.8%9.7%8.7%10.3%7.6%10.6%11.2%
Period end31 Dec 202431 Mar 202530 Jun 202530 Sep 202531 Dec 202531 Mar 202630 Jun 202630 Sep 2026

How net margin is measured

Net margin is net income divided by revenue. Figures are read from the report the company filed and checked against accounting identities; one that does not pass is left blank rather than estimated. See data and methodology.

GE HealthCare Technologies Inc.'s other figures

Net margin of comparable companies

Everything on GEHC, in the terminal.

Twenty years of history, operating KPIs and segments, guidance against results, valuation, insiders and holders, charts and alerts.